Last year, an audit by the U.S. Government Accountability Office found “a potential for unnecessary duplication” among the billions of dollars in research grants funded by national agencies. Some researchers, it seemed, could be winning more than one grant to do the same research.
Prompted by that report, Virginia Tech’s Skip Garner and his colleagues used eTBLAST, which Garner invented, to review more than 630,000 grant applications submitted to the NIH, NSF, Department of Defense, Department of Energy, and Susan G. Komen for the Cure, “the largest charitable funder of breast cancer research in the United States.” The approach was not unlike those by publishers to identify potential article duplications.
In a Comment published today inNature, they report that they found 1,300 applications above a “similarity score” cutoff of 0.8 for federal agencies, and 0.65 for Komen documents — “with 1 indicating identical text in two same-length documents, and more than 1 representing identical text in one piece that is longer than the other.”
A new study in Clinical Chemistry paints an alarming picture of how often scientists deposit data that they’re supposed to — but perhaps not surprisingly, papers whose authors did submit such data scored higher on a quality scale than those whose authors didn’t deposit their data.
Ken Witwer, a pathobiologist at Hopkins, was concerned that a lot of studies involving microarray-based microRNA (miRNA) weren’t complying with Minimum Information About a Microarray Experiment (MIAME) standards supposedly required by journals. So he looked at 127 such papers published between July 2011 and April 2012 in journals including PLOS ONE, the Journal of Biological Chemistry, Blood, and Clinical Chemistry, assigning each one a quality score and checking whether the authors had followed guidelines.
Regular Retraction Watch readers may find the name Grant Steen familiar. Steen has published a number of important papers on retractions, most recently in PNAS. Recently, he approached us for help with what sounds like another project that is likely to increase our understanding of misconduct in science: Steen wants to gather the stories of those involved in fraud. We’re happy to present his explanation of the project, and his requests:
Grant Steen
Why is there fraud in science?
Scientists believe—or at least profess to believe—that science is a process of iteratively approaching Truth. Failed experiments are supposed to serve as fodder for successful experiments, so that clouded thinking can be clarified. Observations that are fundamentally true are thought to find support, while observations that are flawed in some way are supplanted by better observations.
A University of Wisconsin neuroscience researcher falsified “Western blot images as well as quantitative and statistical data” in two NIH-supported papers and three unfunded grant applications, the U.S. Office of Research Integrity (ORI) has found.
An associate professor at Montreal’s McGill University is correcting two papers, one of them in Nature, after a university committee found evidence of falsification, Retraction Watch has learned.
It turns out we missed two more recent retractions from Diederik Stapel. They were nestled in the table of contents of the Journal of Personality and Social Psychology that contained four retractions we covered last week.
A few weeks ago, we reported on the shutdown of Science-Fraud.org, a site dedicated to highlighting problems with scientific papers, thanks to legal threats. At the same time, we noted that Rui Curi, one of the authors whose work had been questioned — and whose lawyers had sent the site a cease-and-desist letter — ended up retracting a paper the site had questioned.